Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’ - T

Venture capitalist Vinod Khosla said artificial intelligence (AI) is rapidly expanding drug discovery, but traditional testing methods have failed to keep pace with the technology’s progress.

AI and Human Tissue Drug Testing On Wednesday, in a post on X, Khosla said AI has produced what he described as a "21st-century hyperabundance of potential new drugs and biological hypotheses," while drug testing still relies heavily on conventional animal studies.

He argued that the industry needs a more human-relevant approach to evaluating potential treatments.

"We are still using 18th-century style animal testing," Khosla wrote.

He pointed to Vivodyne, a biotechnology company developing technology to test drugs using living human tissues at scale.